Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 381,058 |
|
|||||
| News | - | ||||||
| Day High | 33.21 | Low High |
|||||
| Day Low | 31.26 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Tarsus Pharmaceuticals Inc | TARS | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.17 | -0.53% | 32.04 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 32.57 | 31.26 | 33.21 | 32.04 | 32.21 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 7,123 | 381,058 | $ 31.93 | $ 12,168,028 | - | 12.57 - 40.40 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 17:32:52 | priorref | 3,300 | $ 32.04 | USD |
Tarsus Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 1.1B | 34.22M | - | 17.45M | -135.89M | -3.97 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Tarsus Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical TARS Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 32.44 | 34.35 | 31.26 | 32.58 | 373,187 | -0.40 | -1.23% |
| 1 Month | 36.54 | 38.46 | 31.26 | 35.10 | 525,854 | -4.50 | -12.32% |
| 3 Months | 28.72 | 40.40 | 27.445 | 33.81 | 715,845 | 3.32 | 11.56% |
| 6 Months | 13.08 | 40.40 | 12.87 | 26.52 | 696,876 | 18.96 | 144.95% |
| 1 Year | 14.32 | 40.40 | 12.57 | 23.27 | 534,581 | 17.72 | 123.74% |
| 3 Years | 30.52 | 40.40 | 10.8001 | 21.76 | 236,449 | 1.52 | 4.98% |
| 5 Years | 18.30 | 63.69 | 10.8001 | 22.44 | 212,126 | 13.74 | 75.08% |
Tarsus Pharmaceuticals Description
| Tarsus Pharmaceuticals Inc is a late clinical-stage biopharmaceutical company. It is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's lead candidate TP-03, is a novel drug that targets the Demodex mite nervous system to kill the mites. |
